Member Info for _Mr_Big

Talking about 100,000s of doses per month - in sharesoc interiveiw RM still said "hoping to be producing". Not "on track", not "set up", but "hoping"!? afaik there's been no update on how our manufacturing is going.

Not a troll, but very genuine concerns about our company's future. No disrespect to other members of the forum, apart from blind rampers of course.

1. Would it hurt to tell the market who they are? I don't think there were any official statements about it - just RM interview.
2. Absolutely.
3. RM Said "expected Nov 20" when he asked for money. We're two weeks past the middle of Nov. Something as simple as a statement that everything's in place apart from reg approval would be reasonable. They can have the office cat draft the text and RM to read and approve - no costs involved really.
Could we not have applied for reg approval earlier? Lack of foresight?
Not delayed as per RNS, but see my previous posts about nothing happening around Christmas.
4. Home trials were/are an absolute disaster. Blinkers off. This is outright scary.
5. We've been waiting for 4 months already with not much to show for it (yet). Why do you think next 6 months will be different? They might, they might not - if there are no market updates then htf are we supposed to know? In 6 months covid likely won't be such a big issue (vax, new therapeutics, who knows) - has RM already conceded the fight and is hoping for stockpiling to save him?
6. Yes, the drug is great. Can RM deliver it to the market? If not, drug's value is irrelevant.

Science is rock solid, but if you read some rampers on here, they are already selling 100,000s of doses per month via MAP and have P3 trial fully recruited with results ready by end of Feb.
People saying that PR is not needed have as much commercial awareness as the SNG team.

Hate being this negative, but the company's heading towards another f.ck up if they can't get P3 started.

Jesus F Christ.
So where are our Clinigen partners when you need them?

Thank you - this is a good article.
Is this us then, since Novartis ifn was used?
The device doesn't look like ours?

From Covid 119.

Have a good Tuesday everyone.

Thanks Joey - I missed the webinar. But I don't quite understand how they can have patients lined up if we don't know when we're getting final approvals. I read it as "ready to start recruiting".

monti - thanks. As long as there are no delays, the intention has always been to hold until April. We'll see.
I found out a wonderful, if not PC acronym today. SNGL. Let's hope it doesn't apply to SNG.

Good news for Mr Big's bankroll, bad news for humanity. Was expected though.

"Patients are ready to dose"
Really? I did not realise they've been recruited already.

monti - the combination of mushroom treatment from SNG, lack of commercial awareness as mentioned by bg and just generally being grumpy on Monday and having a good think about the company with the blinkers off.
RM said "Start expected by end of November" when he was asking for money at 175 and November's gone. I think we at least deserve an update.
There's only two weeks left of effective Q4 - then everything will shut down for the holidays and bugger all will be done. If we don't get a start, we're looking at mid Jan effective P3 start and up to 6 months (who says it can't be 8?) from there. RM and SNG needed to get their fingers out of the black hole 4 months ago, instead they seem to be shoving them deeper and deeper every day. Are you still wondering why all IIs deserted?
Add to that the car crash of an interview with sharesoc and RM telling us to be excited about home trial data, just for Holgate to slip that only 30 folks have been recruited a day later...Still no confirmation or denial of that figure from the company or our useless PR partners who copy-paste standard form answers. Sack them and get an unpaid graduate to do the same job.
If we get P3 start in the next two weeks, I will calm down. If not, I might regrettably dump into the next tick up.

Yeah, no need for PR. Why would anyone need it!

We'll just do another placing (say, at 30p) to keep the lights on for 6 months while we continue recruiting the home trial arm into Q2 2021.

I'm with you BG.

Millie - the SP is already dead. Company ex cash is currently valued at about 35p by the market. This is half of what it was valued at in April this year on the mere prospect of SNG selling to treat covid - way before any P2 confirmation. So all this rock solid data is worth jack sh.t (negative 20p). Not being able to sell a covid cure during the worst pandemic in the last 100 years screams absolute failure.
It's OK for the brains to think we are going at light speed, but it's RM's job to commercialise this drug and he's getting excited about home trial data instead (all 30 of the participants, half on placebo).

We need somebody who is capable of selling this stuff, otherwise it's just yet another AIM dog that will rely on placings to keep the lights on.

kev - absolutely - but markets (and investors) like certainty. SNG do not communicate anything to the market, and the less they communicate, the less certainty there is. We are being kept in the dark and fed sh.te, and all we have left is hoping that there is actually a lot happening behind the closed doors. Just like we hoped that home trial is being filled in the last 6 months, while in reality nothing was happening.
How are we doing against our "hopes" to be producing 100k treatments per month?
How many treatments we have stockpiled? I hope it's a bit more than 30 treatments but wtfdik.
Has there been any take up of the MAP via Clinigen? If not, why not?
What's the progress on filling the home trial and what are the expected dates for it to be filled and for results?
What has actually been done in the last 4 months?

Plenty of things one can communicate to the market if one wanted to. We have a PR partner ffs - what exactly are they doing?

We now have two weeks left to start the trial (because nothing ever happens in the last two weeks of December) and if that doesn't happen, we're probably looking at mid January for P3 to start, which might kick back the P3 results until Q3 next year. By then we'll likely miss the boat completely. More importantly, the company will be running out of cash and if they do feck all to manage the sp, they'll have to dilute at sub 80p prices, which would be criminal.

If the team failed to catch wave 1, and failed to catch wave 2, it's only natural to have doubts about catching wave 3, and they are not doing much to reassure the investors.

Investo - unfortunately, SNG seems to follow the same pattern. "It's all about the data" in April, but they fail to get enough data for emergency approval after the hospital trial. "Weeks, not months" on 20th July, yet here we are months later with f.ck all to show for it. "P3 by end of November" in RM's interview after the placing, and here we are about to close the last day of November with nothing to show for it. "Home trial recruitment picking up" with fag packet calcs suggesting at least half-full on the sharesoc call, just for Holgate to quote 30 participants a day later.

I just hope the government is a lot more incompetent than the SNG team, but I am starting to think we are the underdogs to win this race.

Have you run these numbers past Mystic Meg?

I'm just taking a wild guess. But valuing this company at £70m at this stage of SNG001 development is just silly. Sooner or later she will gap up.

*then

Morning RNS about P3 start.
10% drop on open, than gradual climb to 140, to finish around 180 by the end of the week.

up

Stock suspended on takeover offer. Re-admitted at £10 per share.

Simples.